Quantcast

Old North News

Thursday, November 21, 2024

North Carolina: Biologics companies were the least FDA inspected companies in North Carolina in April

Webp ijw6s7vbfr36c32lki2m95inya4m

Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website

Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website

In April, one Biologics company received an FDA inspection in North Carolina, according to the U.S. Food and Drug Administration (FDA).

This was the lowest number of inspections per type of company made by the FDA in North Carolina, equalling 14.3% of all inspections in April.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

FDA Inspections in North Carolina During April
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Blood and Blood Products1----
Compliance: Devices--1--
Drug Quality Assurance--1--
Food Composition, Standards, Labeling and Econ2----
Foodborne Biological Hazards31--
Postmarket Assurance: Devices1----
Technical Assistance: Food and Cosmetics1----

MORE NEWS